Onco Care Plus is available at just INR 399 per month, and provides services like free doctor consultation, 15% off on cancer treatment costs, 25% off for diagnostic tests, free nutrition plans, among many more
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
Lynparza is approved in the US, EU, Japan and several other countries for the treatment of patients with gBRCAm, HER2-negative, metastatic breast cancer previously treated with chemotherapy based on results from the OlympiAD Phase III trial
Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system
Selvax's goal is to develop safe, effective and immunological-based treatments for a range of hard-to-treat solid tumours
The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age
AOI is the leading cancer hospital chain of South Asia operating 16 cancer hospitals in the region
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)
A simple blood test detects over 30 types of cancers
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
Subscribe To Our Newsletter & Stay Updated
